APA (7th ed.) Citation

HE, V. G., ST, A., AJ, S., R, F., SH, S., Y, W., . . . ER, N. (2024). Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells. Cancer letters, 597, 217086. https://doi.org/10.1016/j.canlet.2024.217086

Chicago Style (17th ed.) Citation

HE, Vidana Gamage, et al. "Development of NR0B2 as a Therapeutic Target for the Re-education of Tumor Associated Myeloid Cells." Cancer Letters 597 (2024): 217086. https://doi.org/10.1016/j.canlet.2024.217086.

MLA (9th ed.) Citation

HE, Vidana Gamage, et al. "Development of NR0B2 as a Therapeutic Target for the Re-education of Tumor Associated Myeloid Cells." Cancer Letters, vol. 597, 2024, p. 217086, https://doi.org/10.1016/j.canlet.2024.217086.